Synthesis of 2,8-Disubstituted Analogues of Tro¨ger’s Base
39H66N2Sn2: C, 58.52; H, 8.31; N, 3.50. Found: C, 58.45; H,
C
11H); HRMS (FAB+) calcd for C22H1979BrN2O 406.0681, found
406.0673. Anal. Calcd for C22H19BrN2O: C, 64.87; H, 4.70; N,
6.98. Found: C, 64.94; H, 4.82; N, 6.79.
8.22; N, 3.56.
Sin gle Br om in e-Lith iu m Exch a n ge of 2 F ollow ed by
Rea ction w ith a n Electr op h ile: Gen er a l P r oced u r e II.
To a stirred solution of 2,8-dibromo-6H,12H-5,11-methanodi-
benzo[b,f][1,5]diazocine (2) (190 mg, 0.5 mmol) in THF (1.5 mL)
and Et2O (4 mL) at -78 °C was added dropwise 1.6 M n-BuLi
in hexane (344 µL, 0.55 mmol) over 2 min. After 5 min the
electrophile (0.75 mmol) was added dropwise over 1 min and
the reaction mixture was allowed to reach room temperature
over approximately 30 min. The reaction was continued for
15 min additionally before water (2 mL) was added. The layers
were separated and the aqueous layer was extracted with
dichloromethane (3 × 10 mL). The combined organic layers
were dried (MgSO4), filtered, and concentrated in vacuo and
the crude product was purified by CC with EtOAc/heptane as
the eluent.
2-Br om o-8-ca r boxyl-6H,12H-5,11-m eth a n od iben zo[b,f]-
[1,5]d ia zocin e Hyd r och lor id e (6e). To a stirred solution of
2,8-dibromo-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocine (2)
(378 mg, 1.0 mmol) in THF (3 mL) and Et2O (8 mL) at -78 °C
was added dropwise 1.6 M n-BuLi in hexane (684 µL, 1.09
mmol) over 2 min. After 5 min the reaction mixture was
transferred into a saturated solution of CO2 in THF at -78
°C by means of a pipet at -78 °C. The reaction mixture was
concentrated in vacuo and the solid was dissolved in methanol
and treated with a commercial solution of 4 M HCl in 1,4-
dioxane (1 mL). Concentration in vacuo and crystallization
from 2-propanol (9 mL) gave 233 mg (61%) of 6e with
decomposition above 200 °C (2-propanol): 1H NMR (300 MHz,
MeOH-d4) δ 4.43-4.55 (m, 2H), 4.81-5.05 (m, 4H), 7.34-7.51
(m, 4H), 7.78-7.79 (m, 1H), 7.90-7.95 (m, 1H); 13C NMR (75
MHz, MeOH-d4) δ 58.0 (1C), 58.6 (1C), 67.9 (1C), 122.2 (1C),
125.6 (1C), 126.0 (1C), 127.3 (1C), 130.0 (1C), 130.4 (1C), 130.4
(1C), 131.0 (1C), 131.7 (1C), 132.9 (1C), 140.5 (1C), 148.4 (1C),
168.5 (1C, CO2H); IR (KBr) 2829 (br, O-H), 1712, 1692, 1682
cm-1; HRMS (FAB+) calcd for C16H1379BrN2O2 344.0160, found
344.0164. Anal. Calcd for C16H14BrClN2O2: C, 50.35; H, 3.70;
N, 7.34. Found: C, 50.28; H, 3.85; N, 7.45.
2-Br om o-8-(t r ib u t ylst a n n yl)-6H ,12H -5,11-m et h -a n o-
d iben zo[b,f][1,5]d ia zocin e (6f). 6f was prepared following
general procedure II with the addition that the crude product
was redissolved in Et2O (10 mL) and stirred for 1 h with a
10% aqueous solution of KF. The white solid was filtered off
and after separation of the two layers, the aqueous layer was
extracted with DCM (3 × 10 mL). The combined organic layers
were dried (MgSO4), filtered, and concentrated in vacuo and
the crude product was purified by CC, using 2 (192 mg, 0.51
mmol), 1.3 M n-BuLi (427 µL, 0.56 mmol), and tributylstannyl
chloride (206 µL, 0.76 mmol) as the electrophile. CC (EtOAc
(10-20%) in heptane) gave 210 mg (70%) of 6f: mp 55.0-56.0
°C; Rf 0.26 (EtOAc (20%) in heptane); 1H NMR (300 MHz,
CDCl3) δ 0.85-0.90 (m, 9H, 3 × CH3), 0.97-1.02 (m, 6H),
1.27-1.35 (m, 6H), 1.47-1.54 (m, 6H), 4.10-4.34 (m, 4H),
4.62-4.73 (m, 2H), 6.96 (s, 1H), 7.01-7.08 (m, 3H), 7.24-7.28
(m, 2H); 13C NMR (75 MHz, CDCl3) δ 9.7 (3C), 13.8 (3C), 27.5
(3C), 29.2 (3C), 58.4 (1C), 58.8 (1C), 66.8 (1C), 116.6 (1C), 124.7
(1C), 127.0 (1C), 127.3 (1C), 129.9 (1C), 130.4 (1C), 130.5 (1C),
135.0 (1C), 135.6 (1C), 137.3(1C), 147.5 (1C), 147.8 (1C); HRMS
(FAB+) calcd for C27H4079BrN2120Sn (M + H+) 591.1397, found
591.1411. Anal. Calcd for C27H39BrN2Sn: C, 54.94; H, 6.66;
N, 4.75. Found: C, 54.88; H, 6.68; N, 4.73.
2-B r o m o -6H ,12H -5,11-m e t h a n o d i b e n z o [b ,f][1,5]-
d ia zocin e (6a ). 6a was prepared following general procedure
II, using 2 (188 mg, 0.49 mmol), 1.3 M n-BuLi (419 µL, 0.54
mmol), and H2O (2 mL) as the electrophile. CC (EtOAc (40%)
in heptane) gave 141 mg (82%) of 6a : mp 123.5-125.0 °C; Rf
1
0.20 (EtOAc (40%) in heptane); H NMR (300 MHz, CDCl3) δ
4.10-4.18 (m, 2H), 4.23-4.34 (m, 2H), 4.62-4.72 (m, 2H),
6.92-7.26 (m, 7H); 13C NMR (75 MHz, CDCl3) δ 58.5 (1C), 58.8
(1C), 66.9 (1C), 116.6 (1C), 124.3(1C), 125.2 (1C), 126.9 (1C),
127.1 (1C), 127.64 (1C), 127.65 (1C), 129.8 (1C), 130.2 (1C),
130.5 (1C), 147.3 (1C), 147.8 (1C); HRMS (FAB+) calcd for
C15H1379BrN2 300.0262, found 300.0264. Anal. Calcd for C15H13
-
BrN2: C, 59.82; H, 4.35; N, 9.30. Found: C, 59.70; H, 4.40; N,
9.22.
2-B r o m o -8-(t r im e t h y ls ily l)-6H ,12H -5,11-m e t h a n o -
d iben zo[b,f][1,5]d ia zocin e (6b). 6b was prepared following
general procedure II, using 2 (187 mg, 0.49 mmol), 1.3 M
n-BuLi (416 µL, 0.54 mmol), and trimethylsilyl chloride (93
µL, 0.74 mmol) as the electrophile. CC (EtOAc (20%) in
heptane) gave 125 mg (68%) of 6b: mp 140.0-141.0 °C; Rf
1
0.12 (EtOAc (20%) in heptane); H NMR (300 MHz, CDCl3) δ
0.22 (s, 9H, 3 × CH3), 4.12-4.20 (m, 2H), 4.23-4.35 (m, 2H),
4.63-4.74 (m, 2H), 7.02-7.06 (m, 3H), 7.10-7.13 (m, 1H),
7.25-7.35 (m, 2H); 13C NMR (75 MHz, CDCl3) δ -1.0 (3C,-
CH3), 58.4 (1C), 58.8 (1C), 66.8 (1C), 116.6 (1C), 124.5 (1C),
126.9 (1C), 127.0 (1C), 129.8 (1C), 130.3 (1C), 130.5 (1C), 132.2
(1C), 132.6 (1C), 136.0 (1C),147.4 (1C), 148.6 (1C); HRMS
(FAB+) calcd for C18H2179BrN2Si 372.0657, found 372.0657.
Anal. Calcd for C18H21BrN2Si: C, 57.90; H, 5.67; N, 7.50.
Found: C, 58.10; H, 5.62; N, 7.41.
2-Br om o-8-for m yl-6H ,12H -5,11-m et h a n od ib en zo[b,f]-
[1,5]d ia zocin e (6c). 6c was prepared following general
procedure II, using 2 (193 mg, 0.51 mmol), 1.3 M n-BuLi (430
µL, 0.56 mmol), and DMF (59 µL,0.76 mmol) as the electro-
phile. CC (EtOAc (50-60%) in heptane) gave 119 mg (71%) of
6c: mp 204.0-205.5 °C; Rf 0.16 (EtOAc (50%) in heptane); 1H
NMR (300 MHz, CDCl3) δ 4.16-4.23 (m, 2H), 4.28 (s, 2H,
H-13), 4.67-4.75 (m, 2H), 7.00-7.05 (m, 2H), 7.22-7.29 (m,
2-Br om o-8-cyan o-6H,12H-5,11-m eth an odiben zo[b,f][1,5]-
d ia zocin e (6g). 6g was prepared following general procedure
II, using 2 (192 mg, 0.51 mmol), 1.3 M n-BuLi (427 µL, 0.56
mmol), and tosyl cyanide (137 mg, 0.76 mmol) in THF (1 mL)
as the electrophile. CC (EtOAc (40%) in heptane) gave 99 mg
(60%) of 6f: mp 203.0-205.0 °C; Rf 0.18 (EtOAc (40%) in
heptane); 1H NMR (300 MHz, CDCl3) δ 4.10-4.19 (m, 2H),
4.26 (d, J ) 1.2 Hz, 2H), 4.63-4.71 (m, 2H), 6.99-7.06 (m,
2H), 7.16-7.30 (m, 3H), 7.41-7.44 (m, 1H); 13C NMR (75 MHz,
CDCl3) δ 58.3 (1C), 58.5 (1C), 66.6 (1C), 107.5 (1C), 117.1 (1C),
118.8 (1C), 125.9 (1C), 126.9 (1C), 129.1 (1C), 129.5 (1C), 129.8
(1C), 131.0 (1C), 131.2 (1C), 131.5 (1C), 146.6 (1C), 152.7 (1C);
2H), 7.447-7.453 (m, 1H), 7.66-7.69 (m, 1H), 9.83 (s, 1H); 13
C
NMR (75 MHz, CDCl3) δ 58.6 (1C), 58.6 (1C), 66.7 (1C), 117.0
(1C), 125.7 (1C), 126.9 (1C), 128.3 (1C), 128.9 (1C), 129.3 (1C),
129.7 (1C), 129.8 (1C), 130.9 (1C), 132.6 (1C), 146.8 (1C), 154.3
(1C), 191.1 (1C); IR (KBr) 1697, 1680, 1668 cm-1; HRMS
(FAB+) calcd for C16H1379BrN2O 328.0211, found 328.0214.
Anal. Calcd for C16H13BrN2O: C, 58.38; H, 3.98; N, 8.51.
Found: C, 58.50; H, 4.11; N, 8.43.
IR (KBr) 2222 cm-1 (CN); HRMS (FAB+) calcd for C16H12
-
-
79BrN3 325.0215, found 325.0199. Anal. Calcd for C16H12
BrN3: C, 58.91; H, 3.71; N, 12.88. Found: C, 59.07; H, 3.69;
N, 12.75.
2-B r o m o -8-(h y d r o x y p h e n y lm e t h y l)-6H ,12H -5,11-
m eth a n od iben zo[b,f][1,5]d ia zocin e (6d ). 6d was prepared
following general procedure II, using 2 (189, 0.50 mmol), 1.3
M n-BuLi (421 µL, 0.55 mmol), and benzaldehyde (76 µL, 0.75
mmol) as the electrophile. CC (EtOAc (70-80%) in heptane)
gave 125 mg (62%) of 6d as a mixture of diastereomers: mp
98.5-100.0 °C (heptane); Rf 0.42 (EtOAc (80%) in heptane);
1H NMR (300 MHz, CDCl3) δ 2.92 (br s, 1H), 3.99-4.17 (m,
4H), 4.52-4.57 (m, 2H), 5.66-5.67 (m, 1H), 6.84-7.32 (m,
Sin gle Br om in e-Lith iu m Exch a n ge of 6b F ollow ed by
Rea ction w ith a n Electr op h ile: 2-F or m yl-8-(tr im eth yl-
silyl)-6H,12H-5,11-m eth an odiben zo[b,f][1,5]diazocin e (7a).
7a was prepared following general procedure I, using 6b (187
mg, 0.50 mmol), 1.3 M n-BuLi (462 µL, 0.60 mmol), and DMF
(58 µL, 0.75 mmol) as the electrophile. CC (EtOAc (30%) in
heptane) gave 101 mg (63%) of 7a : mp 214.0-215.0 °C; Rf
1
0.18 (EtOAc (40%) in heptane); H NMR (300 MHz, CDCl3) δ
J . Org. Chem, Vol. 67, No. 17, 2002 6013